Purchase Order 75N95020P00552
- Not listed
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc. for induced pluripotent stem (iPS) cell-derived differentiated cells. The $241,459.53 contract is for the supply of various iPS cell-derived cell types, including dopaminergic, GABAergic, and glutamatergic neurons, as well as endothelial cells, to support the National Center for Advancing...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $287,502 firm fixed price purchase order to Fujifilm Cellular Dynamics, Inc. to provide induced pluripotent stem cell-derived neuronal and endothelial cells. The solicitation sought these cell types on a non-competitive basis from the incumbent contractor to maintain consistent data for ongoing biofabrication of three-dimensional tissue models in the Stem...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Fujifilm Cellular Dynamics, Inc., a manufacturer of biologically relevant human cells derived from induced pluripotent stem (iPS) cells. The order includes 50 units of the iCell Astrocytes Kit 01434, 20 units of the iCell DopaNeurons Kit 01279, 10 units of the iCell DopaNeurons Kit 01279, and 40 units of...
- The National Institute on Drug Abuse (NIDA), on behalf of the National Center for Advancing Translational Sciences (NCATS), awarded a $209,264.57 firm-fixed-price purchase order to Fujifilm Cellular Dynamics, Inc. for induced pluripotent stem (iPS) cell-derived differentiated cells. The cells will be used for research projects related to health. The contract is non-competitive and does not have a small business set-aside designation. Fujifilm Cellular Dynamics, Inc. is a foreign-owned,...
- This is a $24,061 firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to the foreign-owned, for-profit manufacturer Fujifilm Cellular Dynamics, Inc. The contract is for the supply of various induced pluripotent stem cell (iPSC)-derived human cell products, including cardiomyocytes, neurons, astrocytes, hepatocytes, and endothelial cells. These specialized cell lines are used in biomedical...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $135,997 firm-fixed price purchase order to Fujifilm Cellular Dynamics, Inc. to provide induced pluripotent stem cell (iPSC)-derived human midbrain floorplate dopaminergic (iCell DopaNeurons) and glutamatergic (iCell GlutaNeurons) neurons. These fully differentiated neurons will be used in a 3D in vitro circuitry model to evaluate...
- This firm-fixed price purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Fujifilm Cellular Dynamics, Inc. is for the delivery of 151 kits of iCell Astrocytes and approximately 190 vials of various neuronal cell types. The $583,098 contract calls for the induced pluripotent stem cell-derived differentiated cells to be shipped in three deliveries from March through April 2023 to the National Center for Advancing Translational...
- This is a $124,070 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC) derived human cell products. The contract is for the delivery of iPSC-derived human neurons and astrocytes, which are biologically relevant cell types used to support biomedical...
- The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $86,251 firm-fixed-price purchase order to Fujifilm Cellular Dynamics, Inc. to provide cryopreserved human induced pluripotent stem cell (iPSC)-derived neurons and related supplements. This non-competitive, brand-name acquisition is intended to support neurotoxicity screening assays. The requirement includes iCell DopaNeurons, iCell GlutaNeurons, and other neuronal cell...
- The Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences awarded a $118,665 firm-fixed-price purchase order to Fujifilm Cellular Dynamics, Inc., a foreign-owned for-profit manufacturer, for the supply of induced pluripotent stem cell-derived human neurons and astrocytes. This award was made on a non-competitive basis to support the Antiviral Program for Pandemics' research into antivirals for neurotropic viruses,...
This purchase order awards Fujifilm Cellular Dynamics, Inc. $349,700 for induced pluripotent stem (iPS) cell-derived differentiated cells to support the National Center for Advancing Translational Sciences within the National Institutes of Health's National Institute on Drug Abuse. The contract delivers over 300 units of various iPS cell-derived differentiated cells to develop three-dimensional tissue models of the brain. A pre-solicitation notice sought capability statements for a potential competitive procurement, but no other offerors responded by the July 2020 deadline, resulting in this non-competitive award to the incumbent contractor. Performance will occur in Madison, Wisconsin under a firm fixed price arrangement through September 2021.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Induced pluripotent stem (iPS) cell-derived differentiated cells | NCATS-20-003434 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Special Notice 1/1 | 7/24/20, 11:10 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $349.7k | 9/3/20 |